
U.S. Commerce Dept. @CommerceGov
Monoclonal antibodies (mAbs), proteins that can bind to specific targets in the body, can fight everything from cancer and rheumatoid arthritis to COVID-19. @NIST and its collaborators have now developed a new line of mAb-producing living cells. https://t.co/YXtGXQvrfq — PolitiTweet.org